InvestorsHub Logo
Followers 212
Posts 22787
Boards Moderated 1
Alias Born 08/12/2015

Re: MoneyGrowing post# 35564

Tuesday, 06/27/2017 6:32:08 PM

Tuesday, June 27, 2017 6:32:08 PM

Post# of 113775
Adva-27a is one of a kind. I believe this is where a chunk of the value is coming from. They need to start phase one of it, but they aren't until mid 2018 due to lack of fundimg. They even say a huge buyout is possible in the filings if phase 1 is a success.

"Unlike Etoposide, and other anti-tumor drugs currently in use, Adva-27a is able to destroy Multidrug Resistant Cancer cells. Adva-27a is the only compound known today that is capable of destroying Multidrug Resistant Cancer. "

Until then, they will try to distribute the other drugs they have a generic patent for.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SBFM News